Repository logo
Log in(current)
Repository logoMIT Open ScholarshipDSpace@MIT
  1. Home
  2. MIT Open Access Articles
  3. MIT Open Access Articles
  4. Revealing disease-associated pathways by network integration of untargeted metabolomics

Revealing disease-associated pathways by network integration of untargeted metabolomics

Thumbnail Image
Download
Name

nihms837238.pdf

Size

1.17 MB

Format

Adobe PDF

Checksum (MD5)

b6990f548d49a277c0a429ee7fc7fffe

Download all files submitted through automated deposit
sword-2018-08-30.original.zip (949.41 KB)
Author(s)
Leidl, Mathias
•
Avila-Pacheco, Julian
•
Pirhaji, Leila
•
Milani, Pamela
•
Curran, Timothy G.
•
Clish, Clary
•
Saghatelian, Alan
•
Fraenkel, Ernest
•
White, Forest M.
Date Issued
August 2016
Journal
Nature Methods
Publisher
Springer Nature
Citation
Pirhaji, Leila, Pamela Milani, Mathias Leidl, Timothy Curran, Julian Avila-Pacheco, Clary B Clish, Forest M White, Alan Saghatelian, and Ernest Fraenkel. “Revealing Disease-Associated Pathways by Network Integration of Untargeted Metabolomics.” Nature Methods 13, no. 9 (August 1, 2016): 770–776.
Version
Author's final manuscript
Abstract
Uncovering the molecular context of dysregulated metabolites is crucial to understand pathogenic pathways. However, their system-level analysis has been limited owing to challenges in global metabolite identification. Most metabolite features detected by untargeted metabolomics carried out by liquid-chromatography-mass spectrometry cannot be uniquely identified without additional, time-consuming experiments. We report a network-based approach, prize-collecting Steiner forest algorithm for integrative analysis of untargeted metabolomics (PIUMet), that infers molecular pathways and components via integrative analysis of metabolite features, without requiring their identification. We demonstrated PIUMet by analyzing changes in metabolism of sphingolipids, fatty acids and steroids in a Huntington's disease model. Additionally, PIUMet enabled us to elucidate putative identities of altered metabolite features in diseased cells, and infer experimentally undetected, disease-associated metabolites and dysregulated proteins. Finally, we established PIUMet's ability for integrative analysis of untargeted metabolomics data with proteomics data, demonstrating that this approach elicits disease-associated metabolites and proteins that cannot be inferred by individual analysis of these data.
MIT Department
Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory
Massachusetts Institute of Technology. Department of Biological Engineering
Massachusetts Institute of Technology. Department of Biology
Terms of Use
Creative Commons Attribution-Noncommercial-Share Alike
http://creativecommons.org/licenses/by-nc-sa/4.0/
Persistent DSpace Link
http://hdl.handle.net/1721.1/117642
DOI of Published Version
https://doi.org/10.1038/NMETH.3940
Repository logo
PrivacyPermissionsAccessibilityContact us
Repository logo
Notify us about copyright concerns.